Numinus Wellness Inc.

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, EXE.TO has a market cap of 2.5B. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while EXE.TO trades at CA$27.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas EXE.TO's P/E ratio is 24.13. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to EXE.TO's ROE of +0.48%. Regarding short-term risk, NUMI.TO is less volatile compared to EXE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check EXE.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, SIA.TO has a market cap of 2.2B. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while SIA.TO trades at CA$22.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas SIA.TO's P/E ratio is 45.02. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to SIA.TO's ROE of +0.07%. Regarding short-term risk, NUMI.TO is less volatile compared to SIA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check SIA.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, DNTL.TO has a market cap of 2.1B. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while DNTL.TO trades at CA$11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas DNTL.TO's P/E ratio is -78.57. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to DNTL.TO's ROE of -0.02%. Regarding short-term risk, NUMI.TO is less volatile compared to DNTL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check DNTL.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, WELL.TO has a market cap of 993.8M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while WELL.TO trades at CA$3.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas WELL.TO's P/E ratio is -129.67. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to WELL.TO's ROE of -0.01%. Regarding short-term risk, NUMI.TO is less volatile compared to WELL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check WELL.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, DR.TO has a market cap of 303.3M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while DR.TO trades at CA$16.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas DR.TO's P/E ratio is 15.27. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to DR.TO's ROE of +0.28%. Regarding short-term risk, NUMI.TO is less volatile compared to DR.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check DR.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, CRRX.TO has a market cap of 227.1M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while CRRX.TO trades at CA$3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas CRRX.TO's P/E ratio is 8.83. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to CRRX.TO's ROE of +0.28%. Regarding short-term risk, NUMI.TO is less volatile compared to CRRX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check CRRX.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, AIDX.TO has a market cap of 225.9M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while AIDX.TO trades at CA$0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas AIDX.TO's P/E ratio is -5.13. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to AIDX.TO's ROE of -0.39%. Regarding short-term risk, NUMI.TO is less volatile compared to AIDX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check AIDX.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, DRDR.TO has a market cap of 49.4M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while DRDR.TO trades at CA$0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas DRDR.TO's P/E ratio is -0.83. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to DRDR.TO's ROE of -1.02%. Regarding short-term risk, NUMI.TO is less volatile compared to DRDR.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check DRDR.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, GTMS.TO has a market cap of 28.6M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while GTMS.TO trades at CA$0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas GTMS.TO's P/E ratio is -0.45. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to GTMS.TO's ROE of +15.74%. Regarding short-term risk, NUMI.TO is less volatile compared to GTMS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check GTMS.TO's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, EPW.CN has a market cap of 4.1M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while EPW.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas EPW.CN's P/E ratio is -0.27. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to EPW.CN's ROE of +0.47%. Regarding short-term risk, NUMI.TO and EPW.CN have similar daily volatility (0.00).Check EPW.CN's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, CALM.CN has a market cap of 2.8M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while CALM.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas CALM.CN's P/E ratio is -0.11. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to CALM.CN's ROE of +3.14%. Regarding short-term risk, NUMI.TO and CALM.CN have similar daily volatility (0.00).Check CALM.CN's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, OMIC.CN has a market cap of 2.3M. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while OMIC.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas OMIC.CN's P/E ratio is -4.50. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to OMIC.CN's ROE of -0.83%. Regarding short-term risk, NUMI.TO and OMIC.CN have similar daily volatility (0.00).Check OMIC.CN's competition here

NUMI.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUMI.TO stands at 16M. In comparison, MEDI.NE has a market cap of 17.8K. Regarding current trading prices, NUMI.TO is priced at CA$0.05, while MEDI.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUMI.TO currently has a P/E ratio of -0.63, whereas MEDI.NE's P/E ratio is -0.02. In terms of profitability, NUMI.TO's ROE is +11.51%, compared to MEDI.NE's ROE of N/A. Regarding short-term risk, NUMI.TO is less volatile compared to MEDI.NE. This indicates potentially lower risk in terms of short-term price fluctuations for NUMI.TO.Check MEDI.NE's competition here